New data confirm the safety and immune benefit of dendritic-cell vaccines in breast cancer; Airomedical helps patients reach ...

Langenfeld, Germany, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Booking Health, a global medical travel platform, announced today the expansion of patient access to dendritic cell immunotherapy for recurrent ...

A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and ...

Global Phase III trial has enrolled and randomised over 170 patients, reaching an important milestone as this is above the amount needed to ...

“Lymph nodes are immune organs where dendritic cells ‘talk' to T cells, giving them direction to go out and find the cancer ...

It is expected that the role of pDCs in MS will be more precisely defined in the near future. This will lead to clinical trials targeting specific molecules to modulate pDC functions. KE Balashov's ...

Favorable safety profile and encouraging early efficacy signals support advancement to Phase II trial of dendritic cell vaccine for the treatment of glioblastoma. "This milestone represents a ...

CD8 + cytotoxic T lymphocytes (CTLs) serve as central effectors in cancer immunotherapy by directly eliminating tumor cells. However, current clinical therapies face significant limitations. These ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus challenges when combined with a mucosal adjuvant that enhances the body's ...

To date, human anti-tumor vaccination has not delivered on its promises. Reasons for failure include tumor immune escape mechanisms, limited availability of tumor specific antigens, as well as failure ...